+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

Psoriasis Vulgaris - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Psoriasis Vulgaris - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Severe Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Severe Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Moderate Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Moderate Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Generalized Pustular Psoriasis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Generalized Pustular Psoriasis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Chronic Plaque Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Plaque Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Phototherapies for Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Phototherapies for Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Generalized pustular psoriasis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Generalized pustular psoriasis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Psoriasis Vulgaris - Epidemiology Forecast to 2032 - Product Thumbnail Image

Psoriasis Vulgaris - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Moderate to Severe Plaque Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Moderate to Severe Plaque Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Etanercept- Biosimilar Insight, 2022 - Product Thumbnail Image

Etanercept- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Moderate Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019 - Product Thumbnail Image

Moderate Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019

  • Drug Pipelines
  • January 2019
  • 120 Pages
  • Global
From
Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019 - Product Thumbnail Image

Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
  • Global
From
Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Type (Biologics v/s Biosimilars), By Product Type, By Therapeutic Area, By Distribution Channel, By End Users, By Region, Forecast & Opportunities, 2028 - Product Thumbnail Image

Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Type (Biologics v/s Biosimilars), By Product Type, By Therapeutic Area, By Distribution Channel, By End Users, By Region, Forecast & Opportunities, 2028

  • Report
  • December 2022
  • 116 Pages
  • Global
From
Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 118 Pages
  • Global
From
Investigation Report on China's Infliximab Market 2022-2031 - Product Thumbnail Image

Investigation Report on China's Infliximab Market 2022-2031

  • Report
  • July 2022
  • 40 Pages
  • China
From
Investigation Report on China's Ustekinumab Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Ustekinumab Market 2021-2025

  • Report
  • May 2021
  • 50 Pages
  • China
From
Investigation Report on China's Adalimumab Market, 2021-2025 - Product Thumbnail Image

Investigation Report on China's Adalimumab Market, 2021-2025

  • Report
  • April 2021
  • 40 Pages
  • China
From
Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry - Product Thumbnail Image

Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry

  • Newsletter
  • May 2024
  • 2 Pages
  • Global
From
Taltz - Product Thumbnail Image

Taltz

  • Report
  • May 2018
  • 47 Pages
  • Global
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more